Isaacson Barash Carol
Helix Health Advisors, 317 Lamartine Street, Suite 200, Boston, MA, USA.
Appl Transl Genom. 2016 Mar 10;9:37-9. doi: 10.1016/j.atg.2016.03.004. eCollection 2016 Jun.
While genomics, and other omics, research is rapidly advancing in the US and Europe, progress has been slower in less resourced countries. The imbalance has given rise to concern about whether the benefits of these advances, namely new and better tests, treatments, risk identification, and prevention strategies, will be shared and available to those living in less resourced reaches of the globe. In effort to give voice to researchers, an informal survey about barriers to advancing translational medicine was administered to attendees of the 11th Asia Pacific Conference on Human Genetics, 2015, Hanoi. The overall goal of the survey was to identify unmet needs and rank their importance. Most attendees completed the survey. Not surprisingly funding is indicated as a major need. Respondents reported that lack of bioinformatics and computational tools, trained data scientists and access to datasets is creating a significant lag behind better resourced regions. Results are intended to inform efforts to create a regional consensus statement of need. Such a regional statement could help funding organizations and policy makers seeking to promote global genomics benefit sharing.
虽然基因组学及其他组学研究在美国和欧洲迅速发展，但在资源较少的国家进展较为缓慢。这种不平衡引发了人们对于这些进展所带来的益处（即新的、更好的检测方法、治疗手段、风险识别和预防策略）是否会被全球资源较少地区的人们所共享和利用的担忧。为了让研究人员能够表达意见，针对2015年在河内举行的第11届亚太人类遗传学会议的与会者进行了一项关于转化医学发展障碍的非正式调查。该调查的总体目标是确定未满足的需求并对其重要性进行排序。大多数与会者完成了调查。不出所料，资金被认为是一项主要需求。受访者表示，缺乏生物信息学和计算工具、训练有素的数据科学家以及获取数据集的机会，使得资源较少的地区相比其他地区存在显著滞后。研究结果旨在为制定区域需求共识声明提供参考。这样一份区域声明有助于资助机构和政策制定者推动全球基因组学利益共享。
